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Introduction: Hypertension, hypercholesterolemia, and diabetes are the main causes of 
cardiovascular diseases in developed countries. However, these conditions are still poorly 
recognized and treated.
Objective: This study aimed at estimating the prevalence, awareness, treatment, and control 
rates of major cardiovascular risk factors in an unselected sample of individuals of a small 
community located in northern Italy.
Methods: We screened 344 sequential subjects in this study. Data collection included family 
and clinical history, anthropometric data, blood pressure, blood glucose, and serum cholesterol 
values. Individual cardiovascular risk profiles were assessed by risk charts of the Progetto 
Cuore.
Results: Based on personal history and/or measured values, 78.2% of subjects had 
hypercholesterolemia (total cholesterol levels . 190 mg/dL), 61.0% had central obesity (waist 
circumference $ 94 cm for men and $80 cm for women), 51.2% had arterial hypertension 
(blood pressure $ 140/90 mmHg), 8.1% had diabetes (blood glucose $ 126 mg/dL), 22.7% had 
impaired fasting glucose (blood glucose 100–125 mg/dL), and 35.5% were overweight (body 
mass index 25–29 kg/m2). Alcohol drinkers and smokers accounted for 46.2% and 22.4% of 
subjects, respectively. Awareness of hypertension, hypercholesterolemia, and diabetes was poor, 
and control of these risk factors, except for diabetes, was even worse. Prevalence of high blood 
pressure, high serum cholesterol, overweight, and obesity significantly increased with aging. 
Hypercholesterolemia and obesity were significantly more common in women, while overweight 
and diabetes in men. In 15.4% of participants, the risk of a major cardiovascular event in the 
next 10 years was either high or very high.
Conclusion: In a small community in a wealthy region of Italy, the prevalence of major car-
diovascular risk factors is high, while awareness, treatment, and control are poor. Such a result 
highlights the importance of screening campaigns as a strategy to improve early diagnosis and 
access to treatment, and thus effective prevention of cardiovascular diseases in the general 
population.
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Introduction
Cardiovascular risk factors, such as high blood pressure, dyslipidemia, diabetes, and 
obesity are considered a major disease burden and account for a large contribution to 
global loss of healthy life due to cardiovascular diseases worldwide.1,2 It is estimated 
that in developed countries millions of deaths are annually attributable to cardiovascular 
disease, but the levels and trends vary from country to country.3–6
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Although age-adjusted cardiovascular death rates 
declined in most developed countries in the past few 
decades,3–6 the prevalence of underlying risk factors and thus 
the hazard of cardiovascular disease changed minimally,7–9 
hence keeping morbidity and mortality rates high. Research 
efforts in recent years have made available simple methods 
for early identification of main cardiovascular risk factors 
and have developed efficient remedies for correcting such 
 abnormalities.  Encouragingly, because most of the risk 
 factors for  cardiovascular disease, such as hypertension, 
unfavorable lipid cholesterol profile, obesity, smoking, physi-
cal inactivity, and to a lesser extent diabetes, are considered 
to be largely modifiable, many deaths and disabilities due to 
cardiovascular disease can be prevented.10,11 Cardiovascular 
disease can be avoided or delayed by combining strategies 
based on early detection, effective treatment, and healthy 
lifestyle changes. Indeed, epidemiologic studies and random-
ized clinical trials have provided compelling evidence that 
coronary disease is largely preventable by addressing known 
risk factors.11–13
Effective prevention of cardiovascular disease by 
adequate control of major cardiovascular risk factors can 
provide substantial and underestimated public health gains. 
However, improvement of detection and control of major 
cardiovascular risk factors in the general population con-
tinues to be a major challenge, because of poor awareness 
of an individual’s status. A solution to this problem might 
be more aggressive and early identification and appropriate 
correction of cardiovascular risk factors through sensitiza-
tion campaigns, where risk factors can be easily checked and 
promptly recognized.
The objective of the present investigation was to evaluate 
the prevalence, awareness, treatment, and control of major 
cardiovascular risk factors in an unselected population of a 
small community located in northern Italy. The study was 
based on a very simple screening program, in order to dem-
onstrate the effectiveness of such an approach for appropriate 
detection of cardiovascular risk factors.
Methods
Study design
This was a community based survey focusing on screen-
ing main cardiovascular risk factors in an unselected 
population. Subjects living in a wide area located North 
of Milan and South of Varese (Northern Italy, Lombardy 
region), were invited through advertisements released in 
pharmacies, general practitioners’ offices, or Italian Red 
Cross local offices, to attend a mobile center to undergo a 
medical checkup. During the visit, in addition to age and sex, 
the following information was obtained from each subject: 
family history for cardiovascular diseases; personal clinical 
history for associated cardiovascular diseases; presence and 
treatment of arterial hypertension, diabetes mellitus, and 
hypercholesterolemia. Subjects were also asked whether they 
were current cigarette smokers or alcohol drinkers. Following 
the interview, anthropometric measurements were taken, 
and blood pressure, serum cholesterol, and blood glucose 
were measured, as detailed in the next sections. Subjects 
were asked to fast for 12 hours before the examination to 
ensure optimal blood test accuracy. They were also allowed 
to take their prescribed drug treatment, if any.
Prior to the examination, participants were asked to give 
written informed consent for collection and analysis of their 
clinical data, according to current Italian law. All visits took 
place between July and October 2007.
Anthropometric measurements
Body height, weight, and waist circumference were all taken 
in a standardized manner.14,15 Body weight and height were 
measured on subjects without shoes and wearing light cloth-
ing (underwear, skirt or pants, and a shirt), using a calibrated, 
professional, electronic scale (Seca GmbH & Co. Kg., 
Hamburg, Germany). Waist circumference was determined 
at minimal respiration by a measuring tape placed around 
the abdomen at the level of the high point of the iliac crest 
and kept parallel respect to the ground. In order to ensure 
accurate measurements, subjects were instructed to gather 
their shirt above the waist, cross their arms, and place their 
hands on opposite shoulders.
Body mass index was calculated as weight divided 
by squared height and expressed as kg/m2. A body mass 
index $ 30 kg/m2 was regarded as compatible with obesity. 
 Overweight was defined by a body mass index ranging between 
25 kg/m2 and 29.9 kg/m2. A waist circumference $ 94 cm in 
males and $80 cm in females was used to define central or 
abdominal obesity, according to the International Federation 
of Diabetes Guidelines.16
Blood pressure measurement
Blood pressure was measured according to current 
recommendations17 using a validated, automatic, electronic, 
upper-arm sphygmomanometer (UA-787, A&D Company 
Limited, Tokyo, Japan),18 with the patient in the sitting 
position for 5 minutes before the measurement. The aver-
age of two consecutive measurements, spaced by an interval 
of 2 minutes was considered as the representative blood 
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pressure value of the subject. Hypertension was defined by 
a systolic blood pressure $ 140 mmHg and/or a diastolic 
blood pressure $ 90 mmHg.19
Blood testing
Following blood pressure measurement, serum total cho-
lesterol, high density lipoprotein cholesterol (HDL), and 
blood glucose concentrations were measured using the 
CardioChek PA analyzer (Polymer Technology Systems Inc, 
Indianapolis, IN, USA).20 Blood samples were taken from 
the index finger. Before the test, the finger was thoroughly 
cleaned with an alcohol preparation and then lanced on the 
side to obtain two drops of blood. The first drop was wiped 
away with a cloth, while the second was used for the test. 
A capillary was placed under the blood drop in order to 
allow collection. The drop was then plunged from capil-
lary onto a test strip placed in the analyzer. Results were 
available within 2 minutes and displayed on the digital 
screen of the analyzer. Two different strips were used, one 
for checking total and HDL cholesterol and one for blood 
glucose.  Precision and accuracy of the CardioChek PA 
analyzer were evaluated and compared in previous valida-
tion studies with clinical diagnostic laboratory methods and 
found to be acceptable.20
Metabolic abnormalities were detected in presence of a 
total cholesterol . 190 mg/dL (hypercholesterolemia), HDL 
cholesterol , 40 mg/dL in males and ,50 mg/dL in females, 
and blood glucose $ 126 mg/dL (diabetes). Impaired fast-
ing glucose was defined as a blood glucose ranging between 
100 mg/dL and 125.9 mg/dL. Dyslipidemia was diagnosed 
in the presence of elevated total cholesterol and/or low HDL 
cholesterol.
Thresholds for identification of all the aforementioned 
cardiovascular risk factors were based on indications issued 
by the European Society of Hypertension and Cardiology, 
the International Federation of Diabetes and the American 
Diabetes Association.16,19,21
Data analysis
At the time of the examination, data from each subject 
were reported on a paper sheet. Individual data were then 
entered into an electronic database to allow pooled analysis. 
Patients were considered having hypertension, hypercho-
lesterolemia, or diabetes mellitus on the basis of a previ-
ous diagnosis by a general practitioner or a specialist or if 
they were under specific drug treatment, or on the basis of 
the measured blood pressure, serum cholesterol, or blood 
glucose levels.
The degree of individual cardiovascular risk was estab-
lished according to the Progetto Cuore equation. This is 
an algorithm derived from and validated in a large Italian 
cohort of individuals, predicting the risk of fatal and non-
fatal major coronary events in the next 10 years. The equa-
tion fits together age, sex, systolic blood pressure, total 
cholesterol, HDL cholesterol, smoking status, and treatment 
for diabetes or for high blood pressure.22,23
The prevalence of the various cardiovascular risk factors 
was assessed by computing the absolute (n) and relative (%) 
frequency of occurrence for the whole sample of subjects, 
and for subgroups, according to decades of age (,40, 40–49, 
50–59, 60–69, and $70 years) and sex (male or female). 
 Continuous variables were also calculated and expressed 
as means ± standard deviation. Differences in percentages 
were compared using the Chi-square test and differences 
in means by analysis of variance. A P-value , 0.05 was 
considered significant.
Results
A total of 344 subjects were screened and enrolled in this 
study. Demographic, anthropometric, and clinical data of the 
participants are presented in Table 1. Mean subject age was 
54.9 years, and females were slightly more prevalent than 
males (52.6% versus 47.4%). A positive family history for 
hypertension was reported by 38.1% of subjects, followed in 
frequency by diabetes (25.9%), and premature cardiovascular 
disease (myocardial infarction [19.2%] and stroke [6.1%]). 
A personal history of cardiovascular disease was recorded 
in 18.9% of subjects.
As shown in Figure 1, considering either a previous diagno-
sis or values measured during the examination  (anthropometric 
data, blood pressure values, and blood tests), the most common 
cardiovascular risk factors were, in decreasing order, hyper-
cholesterolemia (78.2% of subjects), followed by central obesity 
(61.0%), and hypertension (51.2%). Elevated total cholesterol 
and/or low HDL cholesterol (dyslipidemia) were reported in 
the majority of subjects (86.0%). Current alcohol drinkers and 
smokers accounted for 46.2% and 22.4% of the total sample, 
respectively. An obese state (body mass index $ 30 kg/m2) was 
observed in 10.2% of subjects, while overweight (body mass 
index $ 25 and ,30 kg/m2) was displayed by 35.5% of subjects. 
The overall prevalence of diabetes was 8.1%, while impaired 
fasting glucose was observed in 22.7% of subjects.
Blood pressure
Arterial hypertension (systolic blood pressure $ 140 or 
 diastolic blood pressure $ 90 mmHg or previous diagnosis) 
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all  subjects; Figure 2A). Only a limited portion of subjects 
aware of hypercholesterolemia were on lipid-lowering 
medication (31.0%): of these, only 25.0% had a total serum 
cholesterol # 190 mg/dL (Figure 2B).
Low serum HDL cholesterol (,40 mg/dL in males 
and ,50 mg/dL in females) was observed in 20.3% of sub-
jects, while dyslipidemia (high total serum cholesterol and/or 
low HDL cholesterol) was reported in 82.8% of subjects.
Blood glucose
Of the examined subjects, 8.1% had high blood glucose 
($126 mg/dL) or previously diagnosed diabetes, of whom 
Table 1 Demographic and clinical characteristics of the 
344 subjects of the study population
n = 344
Age (years) 54.9 ± 15.1 (19–85)
Age class (years)
 ,40 59 (17.2)
 40–49 67 (19.5)
 50–59 72 (20.9)
 60–69 87 (25.3)
 $70 59 (17.2)
Sex
 Male 163 (47.4)
 Female 181 (52.6)
Family history for cardiovascular disease 233 (67.7)
 Arterial hypertension 131 (38.1)
 Diabetes 89 (25.9)
 Myocardial infarction 66 (19.2)
 Stroke 21 (6.1)
 Kidney disease 13 (3.8)
 Dyslipidemia 7 (2.0)
Personal history for cardiovascular disease 65 (18.9)
 Ischemic heart disease 7 (2.0)
 Heart failure 7 (2.0)
 Peripheral artery disease 7 (2.0)
 Kidney disease 6 (1.7)
 Myocardial infarction 5 (1.5)
 Stroke 2 (0.6)
Height (cm) 166.1 ± 8.6 (144–190)
Weight (kg) 69.4 ± 13.1 (40–170)
BMI (kg/m2) 25.1 ± 4.0 (15.1–43.1)
Waist circumference (cm) 90.6 ± 12.2 (62–126)
SBP (mmHg) 135.9 ± 23.0 (81.5–235)
DBP (mmHg) 79.7 ± 11.3 (50.5–114.0)
Total serum cholesterol (mg/dL) 220.8 ± 51.1 (100–379)
HDL serum cholesterol (mg/dL) 57.5 ± 17.5 (15–100)
Blood glucose (mg/dL) 91.8 ± 21.4 (33–192)
Smoking 77 (22.4)
Alcohol 159 (46.2)
Notes: Data are shown as means ± SD and ranges (in brackets), or as absolute 
(number) and relative frequencies (percentages).
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL, high 
density lipoprotein; SBP, systolic blood pressure; SD, standard deviation.
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Figure 1 Prevalence of major cardiovascular risk factors in the 344 subjects of the 
study.
Note: Data are reported as percentages (%) of the total number.
Abbreviation: HDL, high density lipoprotein.
was present in 51.2% of subjects, of whom 55.7% were aware 
(28.5% of all subjects) and 44.3% were not aware (22.7% 
of all subjects) of their condition (Figure 2A). The majority 
of subjects with hypertension (92.9%) were using specific 
antihypertensive medications, but only 31.9% of them had 
controlled blood pressure (,140/90 mmHg; Figure 2B).
Serum cholesterol
Hypercholesterolemia (total serum cholesterol . 190 mmHg or 
previous diagnosis) was the most common major cardiovas-
cular risk factor, affecting 78.2% of the screened subjects: 
43.1% of these individuals (33.7% of all subjects) were 
aware of their condition, while 56.9% were not (44.5% of 
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Figure 2 Prevalence (open bars), awareness (striped bars), and lack of awareness 
(full bars) of hypertension, hypercholesterolemia or diabetes in the 344 subjects of 
the study (A). Rates of treated (open bars) and of treated and controlled subjects 
(full bars) are shown in (B).
Note: Data are summarized as percentages (%).
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Figure 3 Mean values ± SD for BMI, waist circumference, S and D blood pressure, 
total and HDL serum cholesterol and blood glucose in the 344 subjects of the study 
according to decades of age.
Notes: P-values indicate the level of statistical significance for the trend analysis.
Abbreviations: BMI, body mass index; D, diastolic; HDL, high density lipoprotein; 
S, systolic; SD, standard deviation.
Prevalence of impaired fasting glucose increased with age 
(from 16.9% for subjects , 40 years to 32.2% for subjects 
$ 70 years, P = 0.053), this also being the case for dyslipidemia 
(from 66.1% to 88.1%, P = 0.006), overweight (from 25.4% to 
45.8%, P = 0.022), obesity (from 5.1% to 10.2%, P = 0.231), 
and central obesity (from 33.9% to 81.4%, P = 0.0001).
Cardiovascular risk factors and sex
Body mass index, waist circumference, blood pressure, and 
blood glucose were significantly higher and total cholesterol 
and HDL cholesterol significantly lower in males compared 
to females (Figure 4). The prevalence, awareness, treatment, 
and control of hypertension did not significantly differ among 
sexes, while hypercholesterolemia was more common in 
females and diabetes in males.
Impaired fasting glucose was more prevalent in males 
(23.9% versus 21.5% females, P = 0.008), this was also 
the case for overweight (44.8% versus 27.1%, P = 0.003). 
Conversely, dyslipidemia, obesity, and central obesity were 
more common in females (89.0%, 11.0%, and 66.9% versus 
76.1%, 9.2%, and 54.6% in males, P = 0.002, P = 0.0571, 
and P = 0.020, respectively).
Overall cardiovascular risk
Cardiovascular risk factors (dyslipidemia, high blood pres-
sure, diabetes or impaired fasting glucose, overweight or 
obesity, cigarette smoking, and alcohol drinking) tended to be 
grouped, with 37.8% of participants displaying 1–2 of such 
risk factors, 59.9% $ 3, and 2.3% none (P = 0.0001). When 
only the four major cardiovascular risk factors (dyslipidemia, 
hypertension, diabetes, and obesity) were considered, $3 of 
them were recorded in 38.4% of individuals, 1–2 in 57.0%, 
and none in 4.7% (P = 0.0001).
In the whole study population the average ± standard 
deviation risk of a major cardiovascular event in the next 
10 years was 7.3% ± 10.4%, with 61.9% of subjects in the low 
class risk (,5%), 22.7% in the mid (5%–10%), 5.5% in the 
high-moderate (15%–20%), 5.2% in the high (20%–30%), and 
4.7% in the very high ($30%) class (P = 0.0001). When the 
65 subjects with a positive history for a previous cardiovascular 
disease were excluded from cardiovascular risk estimation, the 
score averaged to 6.3% ± 9.1% with 52.9% of subjects in the 
low, 17.4% in the mid, 4.1% in the high-moderate, 3.8% in 
the high, and 2.9% in the very high risk classes (P = 0.0001).
Discussion
In recent years, the prevalence of hypertension, dyslipidemia, 
diabetes, and obesity underwent a dramatic increase in 
57.1% were aware (4.7% of all subjects) and 42.9% 
were not aware (3.5% of all subjects) of their condition 
(Figure 2A). Most of the patients with diabetes (62.5%) 
were under pharmacological treatment yet still had a blood 
glucose , 126 mg/dL (60.0%; Figure 2B).
Cardiovascular risk factors and age
As shown in Figure 3, average values of body mass index, 
waist circumference, systolic blood pressure, total serum 
cholesterol, and blood glucose significantly increased and dia-
stolic blood pressure and serum HDL cholesterol significantly 
decreased with age. Diastolic blood pressure and total and 
HDL cholesterol values plateaued at advanced age. Prevalence 
and awareness of hypertension, hypercholesterolemia, and 
diabetes, as well as percentages of treated subjects increased 
with age, while control of risk factors was progressively 
less common from the youngest to the oldest age (Table 2). 
However, trend analysis revealed a statistically significance 
increase as a function of age only for prevalence and awareness 
of high blood pressure and elevated total cholesterol.
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Table 2 Prevalence, treatment, and control of hypertension, hypercholesterolemia, and diabetes according to age and sex
n Total prevalence Aware Not aware n Treated n Controlled
Hypertension
Age class (years)
 ,40 59 7 (11.9) 3 (5.1) 4 (6.8) 3 2 (66.7) 2 –
 40–49 67 20 (29.9) 4 (6.0) 16 (23.9) 4 3 (75.0) 3 2 (66.7)
 50–59 72 36 (50.0) 16 (22.2) 20 (27.8) 16 14 (87.5) 14 7 (50.0)
 60–69 87 64 (73.6) 43 (49.4) 21 (24.1) 43 42 (97.7) 42 10 (23.8)
 $70 59 49 (83.1) 32 (54.2) 17 (28.8) 32 30 (93.8) 30 10 (33.3)
P-value 0.0001 0.0001 0.027 0.123 0.198
Sex
 Male 163 88 (54.0) 47 (28.8) 41 (25.2) 47 44 (93.6) 44 13 (29.5)
 Female 181 88 (48.6) 51 (28.2) 37 (20.4) 51 47 (92.2) 47 16 (34.0)
P-value 0.320 0.893 0.297 0.779 0.645
Hypercholesterolemia
Age class (years)
 ,40 59 30 (50.8) 6 (10.2) 24 (40.7) 6 1 (16.7) 1 –
 40–49 67 52 (77.6) 21 (31.3) 31 (46.3) 21 3 (14.3) 3 –
 50–59 72 61 (84.7) 22 (30.6) 39 (54.2) 22 6 (27.3) 6 2 (33.3)
 60–69 87 76 (87.4) 44 (50.6) 32 (36.8) 44 15 (34.1) 15 6 (40.0)
 $70 59 50 (84.7) 23 (39.0) 27 (45.8) 23 11 (47.8) 11 1 (9.1)
P-value 0.0001 0.0001 0.258 0.153 0.304
Sex
 Male 163 118 (72.4) 48 (29.4) 70 (42.9) 48 19 (39.6) 19 7 (36.8)
 Female 181 151 (83.4) 68 (37.6) 83 (45.9) 68 17 (25.0) 17 2 (11.8)
P-value 0.013 0.112 0.587 0.095 0.083
Diabetes
Age class (years)
 ,40 59 2 (3.4) 1 (1.7) 1 (1.7) 1 – – –
 40–49 67 3 (4.5) 2 (3.0) 1 (1.5) 2 – – –
 50–59 72 5 (6.9) 3 (4.2) 2 (2.8) 3 3 (100.0) 3 (100.0)
 60–69 87 11 (12.6) 7 (8.0) 4 (4.6) 7 5 (71.4) 2 (40.0)
 $70 59 7 (11.9) 3 (5.1) 4 (6.8) 3 2 (66.7) 1 (50.0)
P-value 0.160 0.419 0.451 0.133 0.233
Sex
 Male 163 21 (12.9) 10 (6.1) 11 (6.7) 10 7 (70.0) 7 5 (71.4)
 Female 181 7 (3.9) 6 (3.3) 1 (0.6) 6 3 (50.0) 3 1 (33.3)
P-value 0.002 0.215 0.002 0.424 0.260
Notes: Data are reported as absolute values and percentages, in brackets. P-values refer to the statistical significance of the difference across ages (trend analysis) and 
between sexes.
developed countries and these chronic conditions have been 
associated with cardiovascular disease.1,8,9 It is currently esti-
mated that in a few years ischemic heart disease and cerebro-
vascular disease will become the leading cause of the global 
health burden and a major social problem, both in terms of 
disability-adjusted life years and increased national health 
expenditures.24,25 Thus, early identification and adequate 
treatment of cardiovascular risk factors is important in order 
to reduce the risk of major cardiovascular disease.
Our study was carried out in a relatively small population 
living in a highly developed and wealthy area of Northern Italy, 
devised to evaluate the prevalence, awareness, and control of 
major cardiovascular risk factors in an unselected sample of 
individuals. Surprisingly, we found that high blood pressure, 
high serum cholesterol, diabetes, and obesity, are still highly 
prevalent and their control appears still largely unsuccessful, 
because of both poor patient awareness and lack of pharma-
cological treatment. Hypercholesterolemia and hypertension 
were among the most common risk factors for cardiovascular 
disease, recorded in 78% and 51% of subjects, respectively. 
Interestingly, central obesity, determined by measuring waist 
circumference, ranked high, with a prevalence of 61%, a per-
centage much larger than obesity assessed by calculating body 
mass index (10%). Overweight and impaired fasting glucose, 
two often underreported risk factors,1,11,19,21 were recorded 
in 36% and 23% of participants, respectively. As expected, 
diabetes affected a lower proportion of subjects (8%). Our 
findings are consistent with and add to those observed in larger 
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studies performed in Italy, with some variability according to 
the area of the country.26–35 These also confirm results from 
European9,36 and North American studies.37–41
One of the most interesting results of our study relates to 
the poor awareness, treatment, and control of cardiovascu-
lar risk factors. First, only approximately 50%–60% of the 
examined subjects were aware of their elevated total serum 
cholesterol, high blood pressure, or diabetes, while in the rest 
of the sample these conditions remained undiagnosed. Second, 
most of the hypertensive (90%) and diabetic subjects (60%) 
were pharmacologically treated, while only 30% of subjects 
with elevated total cholesterol reported using cholesterol 
lowering medications. Third, the majority of participants were 
not suitably treated for their specific cardiovascular risk factor. 
Specifically, blood pressure values were ,140/90 mmHg and 
total serum cholesterol # 190 mg/dL in 30% and 25% of 
treated subjects, respectively. On the other hand, the propor-
tion of diabetic subjects achieving target blood glucose levels 
(below 126 mg/dL) was higher, and occurred in approximately 
60% of treated subjects. Lack of adequate pharmacological 
treatment and control resulted in 15% of participants being 
at high or very high risk and 6% at high–moderate risk of a 
major cardiovascular event in the next 10 years.
Interestingly, our findings on awareness, treatment, and 
control of major cardiovascular risk factors are in line with 
those of large epidemiological studies performed in European 
countries and North America. In all of these studies, the 
examined subjects reported a disappointingly low knowledge 
of their own cardiovascular risk status and a completely inad-
equate achievement of the targets defined in the prevention 
guidelines.1,9,36–40
Some additional results of our study deserve to be dis-
cussed. First, increasing age was associated with a signifi-
cantly augmented prevalence of most major cardiovascular 
risk factors, with the exception of diabetes, probably because 
of the very limited number of diabetics included in our 
sample. These results are in accordance with those of previ-
ous studies in Italian27,28,30,31,34 and North-American popula-
tions.37–41 Also, the proportion of subjects treated for arterial 
hypertension, dyslipidemia, or diabetes increased with age, 
but the chance of being controlled did not display a favor-
able trend. Again, overweight and central obesity showed a 
net increase with age, appearing as a relevantly prevalent 
phenomenon associated with aging.34,39
Second, prevalence of cardiovascular risk factors was 
similar between males and females, with the exception of 
hypercholesterolemia and obesity, which were more prevalent 
in females, and diabetes and overweight, which were more 
prevalent in males, confirming evidence from previous large 
scale epidemiological studies.27,31,40
Study limitations
We acknowledge that our study has some limitations, primar-
ily related to its study design. First, we recruited subjects 
through health centers, and thus the chance that participants 
in our survey come from a selected population is high, and 
we cannot exclude that respondents to our survey were par-
ticularly motivated to participate in the screening program, 
as they were already aware of their condition. Likely, a more 
random recruitment process could have been resulted in lower 
awareness or lower rate of previously diagnosed subjects. 
This might be the case particularly for hypertension, because 
almost the majority of hypertensive and diabetic patients were 
treated. However, on the other hand, only 20% of the subjects 
had a personal history of cardiovascular disease and approxi-
mately half of the subjects had no specific knowledge of their 
cardiovascular status, so our study is well balanced and may 
be appropriately defined as a prevalent primary prevention 
screening campaign. Second, data included in the analysis 
were collected in a relatively narrow and selected area of the 
country and on a relatively small sample of individuals. We 
acknowledge that the sample may not reflect the overall situa-
tion of the country and conclusions regarding the prevalence, 
treatment, and control may not be generalized or extended to 
other populations with a different risk profile. Notably, our 
results were not much different from those observed in larger 
samples of the Italian population.26–35 Third, finger-prick 
cholesterol and glucose tests have been reported to provide 
potentially unreliable results.42–44 However, the device used 
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in our study has been validated against clinical diagnostic 
laboratory methods and proven to perform acceptably, pro-
viding health care professionals a rapid point of care method 
for lipid measurement.20,45 Finally, we were unable to get a 
complete blood lipid profile, because we could not measure 
serum triglycerides, and thus we could not derive LDL 
cholesterol or check the prevalence of metabolic syndrome, 
which might have helped to better define the cardiovascular 
risk profile of the screened subjects.
Conclusion
Our small-scale study indicates that major cardiovascular risk 
factors are highly prevalent in a wealthy general population 
of Northern Italy. The poor awareness of these conditions, 
the failure to start appropriate treatment, and lack of effective 
control of such risk factors suggest that more effective and 
comprehensive actions to detect, treat, and control patients at 
risk of cardiovascular events should be promptly undertaken. 
Whether our finding is a consequence of patients’ unwilling-
ness, physician inertia, or bureaucratic difficulties inherent 
to the health care system remains to be clarified. However, 
our study clearly demonstrates that population screening 
campaigns may represent simple and relatively inexpensive 
measures that may contribute to ameliorate cardiovascular 
risk detection, which is a first step for effective prevention 
of cardiovascular diseases. Effective public health measures 
and strategies are needed to improve prevention, diagnosis, 
and access to treatment for the general population at risk of 
cardiovascular events.
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